- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02408289
The Randomized Controlled Cocoa-Appetite Trial
January 12, 2016 updated by: James Greenberg, Brooklyn College of the City University of New York
A Pilot Randomized Human Trial on The Effects of Cocoa on Appetite.
The purpose of this study is to determine whether high-flavonoid cocoa can decrease appetite in humans.
In addition the study is designed to test epicatechin, a compound found in cocoa and procyanidins, a class of compounds found in cocoa, for their ability to decrease appetite in humans.
Study Overview
Status
Completed
Conditions
Detailed Description
The study is a four-way randomized double-blinded crossover trial with randomization balanced for beverage and lab visit order.
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Brooklyn, New York, United States, 11210
- Brooklyn College of the City University of New York
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- stable-weight, as indicated by weight gain or loss of <2% in the past 6 months;
- engaging in only mild exercise< twice a week;
- moderate alcohol users, <2 drinks/day;
- willing to eat pizza.
- mentally and physically healthy.
Exclusion Criteria:
- smokers regular;
- frequent drinkers of coffee, tea or cola sodas, >daily;
- underweight or obese (BMI: <18.5 or >30 Kg/m2);
- allergies to chocolate, cocoa, green tea, coffee or pizza;
- using medication;
- interested in registering in the future for the course Health & Nutrition Sciences 2140, Introduction to the U.S. Health Care System, that is often taught by the PI of the proposed study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Lo-Flav
Low-flavonoid cocoa powder with 0 mg of procyanidins and 0 mg epicatechin per kg of body weight will be consumed as a beverage
|
low-flavonoid cocoa powder with 0 mg of procyanidins and 0 mg epicatechin per kg of body weight will be consumed as a beverage.
|
|
Active Comparator: Hi-Flav
Cocoa powder with 3.8 mg procyanidins per kg of body weight and 0.6 mg Epicatechin per kg of body weight will be consumed as a beverage.
|
High-flavonoid cocoa powder with 3.8 mg procyanidins per kg of body weight and 0.6 mg Epicatechin per kg of body weight will be consumed as a beverage.
|
|
Active Comparator: Epicatechin
Low-flavonoid cocoa powder plus 1 mg epicatechin per kg of body weight will be consumed as a beverage.
|
Low-flavonoid cocoa powder plus 1 mg epicatechin per kg of body weight will be consumed as a beverage
|
|
Active Comparator: Procyanidins
Low-flavonoid cocoa powder plus 3.7 mg procyanidins per kg of body weight will be consumed as a beverage.
|
Low-flavonoid cocoa powder plus 3.7 mg procyanidins per kg of body weight will be consumed as a beverage.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Appetite as assessed by amount of pizza eaten.
Time Frame: Two and a half hours
|
Amount of pizza eaten to be assessed two and one half hours after ingestion of the beverage.
|
Two and a half hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Appetite as assessed by a Visual Analog Scale
Time Frame: Two and one half hours
|
Visual Analog Scale assessments to be conducted during the two and one half hours after ingestion of the beverage.
|
Two and one half hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: James Greenberg, Ph.D, Department of Health & Nutritional Sciences, Brooklyn College of the City University of New York
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2015
Primary Completion (Actual)
May 1, 2015
Study Completion (Actual)
May 1, 2015
Study Registration Dates
First Submitted
April 2, 2015
First Submitted That Met QC Criteria
April 2, 2015
First Posted (Estimate)
April 3, 2015
Study Record Updates
Last Update Posted (Estimate)
January 13, 2016
Last Update Submitted That Met QC Criteria
January 12, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PSC-CUNY 66522-0044
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on Lo-Flav
-
Brendon Gurd, PhDUnknownTime-course of Mitochondrial Biogenic Gene and Protein Expression in Exercised Human Skeletal MuscleMitochondrial BiogenesisCanada
-
University Hospital, AlexandroupolisUnknownAspiration of Subglottic SecretionsGreece
-
University of Kansas Medical CenterAmgenTerminatedProstate CancerUnited States
-
Universidad de los Andes, ChileComisión Nacional de Investigación Científica y TecnológicaRecruiting
-
Federico II UniversityAzienda Sanitaria Locale Napoli 2 NordRecruiting
-
Swiss Paraplegic Research, NottwilRecruitingSpinal Cord InjurySwitzerland
-
Canadian University DubaiNot yet recruitingCognitive Interference and Selective AttentionUnited Arab Emirates
-
Brooke Army Medical CenterThe Geneva FoundationCompleted
-
London North West Healthcare NHS TrustSt Mark's FoundationCompletedPatients With Potential Colorectal NeoplasiaUnited Kingdom
-
Centre Hospitalier de RoanneCompletedRespiration, Artificial | Deep SedationFrance